Luminacin G2
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Enzyme inhibitors |
| Catalog number | BBF-02280 |
| CAS | |
| Molecular Weight | 464.55 |
| Molecular Formula | C25H36O8 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
It is produced by the strain of Streptomyces sp. Mer-VD1207. It has a strong inhibitory effect on capillary formation (IC50 is less than 0.1 μg/mL), Luminacin D has the strongest activity.
- Specification
- Properties
- Price Product List
| IUPAC Name | 3-[2-[(2S,4R,8R)-2-ethyl-4,8-dihydroxy-1,7-dioxaspiro[2.5]octan-6-yl]hexanoyl]-2,6-dihydroxy-5-(2-methylpropyl)benzaldehyde |
| Canonical SMILES | CCCCC(C1CC(C2(C(O2)CC)C(O1)O)O)C(=O)C3=C(C(=C(C(=C3)CC(C)C)O)C=O)O |
| InChI | InChI=1S/C25H36O8/c1-5-7-8-15(18-11-19(27)25(24(31)32-18)20(6-2)33-25)22(29)16-10-14(9-13(3)4)21(28)17(12-26)23(16)30/h10,12-13,15,18-20,24,27-28,30-31H,5-9,11H2,1-4H3/t15?,18?,19-,20+,24-,25?/m1/s1 |
| InChI Key | MCZMNWYYIJABPO-BXWWUWCWSA-N |
| Appearance | White to Pale-yellow Powder |
| Solubility | Soluble in Methanol, Chloroform |
| BBF-03884 | Formononetin | Inquiry |
| BBF-01829 | Deoxynojirimycin | Inquiry |
| BBF-00852 | Epothilon B | Inquiry |
| BBF-00745 | Cefteram pivoxil | Inquiry |
| BBF-05728 | Maytansinol | Inquiry |
| BBF-03915 | Clavulanate Potassium (1:1 mixture with silicon dioxide) | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
